Concepedia

Douglas C. Behenna

DC

33

Publications

3.4K

Citations

25

H-Index

2001

Active since

Affiliations

California Institute of Technology(Current)

Pfizer (United States)

Johnson Foundation

University of Pennsylvania

Beckman Research Institute

Douglas C. Behenna is an author at California Institute of Technology specializing in chemistry, engineering, and organic chemistry.

Top concepts

ChemistryEngineeringOrganic ChemistryCatalysisNatural SciencesChemical EngineeringBiomolecular EngineeringMedicinePharmacologyDiversity-oriented Synthesis

Publications per year

2001–2021

33

Publications

33

The Enantioselective Tsuji Allylation

Douglas C. Behenna, Brian M. Stoltz · Journal of the American Chemical Society · 2004 · 549 citations

Enantioselective Tsuji Allylation, Chemical Engineering, Enol Silanes +10

Deracemization of Quaternary Stereocenters by Pd‐Catalyzed Enantioconvergent Decarboxylative Allylation of Racemic β‐Ketoesters

Justin T. Mohr, Douglas C. Behenna, Andrew M. Harned et al. · Angewandte Chemie International Edition · 2005 · 374 citations

Cc Bond-breaking, Racemic β‐Ketoesters, Engineering +12

Enantioselective construction of quaternary N-heterocycles by palladium-catalysed decarboxylative allylic alkylation of lactams

Douglas C. Behenna, Yiyang Liu, Taiga Yurino et al. · Nature Chemistry · 2011 · 241 citations

Chemical Engineering, Engineering, Quaternary N-heterocycles +7

Enantioselective Decarboxylative Alkylation Reactions: Catalyst Development, Substrate Scope, and Mechanistic Studies

Douglas C. Behenna, Justin T. Mohr, Nathaniel H. Sherden et al. · Chemistry - A European Journal · 2011 · 201 citations

Prochiral Enolate, α-Quaternary Ketones, Mechanistic Studies +11

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller et al. · Cancer Cell · 2021 · 172 citations

Tumor Biology, Oncology, Cdk2/4/6 Inhibitor +10

Rows per page

1–5 of 33